it's only a matter of time before the world will have no choice but to wake up to (a) the potential and effectiveness of Relenza but also (b) the ineffectiveness of Tamiflu for a variety of cases, which is not so much focussed on the pandemic but mainly in the seasonal flu space.
patience, the swiss don't have a monopoly on this market for long!
BTA Price at posting:
$1.76 Sentiment: LT Buy Disclosure: Held
